Skip to main content
Clinical Trials/IRCT20210827052297N1
IRCT20210827052297N1
Recruiting
Phase 3

The comparison of duration of analgesia after cesarean section under spinal anesthesia with Ropivacaine-Fentanyl and Ropivacaine-Sufentanil

Ahvaz University of Medical Sciences0 sites44 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pain after cesarean section.
Sponsor
Ahvaz University of Medical Sciences
Enrollment
44
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
Female

Investigators

Eligibility Criteria

Inclusion Criteria

  • Age between 17 to 45 years old
  • ASA Class I and II
  • Candidate for elective cesarean section
  • No allergies to fentanyl, sufentanil and ropivacaine
  • no history of addiction
  • Consent to participate in the study

Exclusion Criteria

  • Severe liver disease
  • Need for general anesthesia

Outcomes

Primary Outcomes

Not specified

Similar Trials